SYK Valuation

Stryker Corp

Add to Watchlist

Advanced Chart

365.470

-7.95(-2.129%)1D

SYK Relative Valuation

SYK's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, SYK is overvalued; if below, it's undervalued.

Historical Valuation

Stryker Corp (SYK) is now in the Undervalued zone, suggesting that its current forward PE ratio of 25.76 is considered Undervalued compared with the five-year average of 26.35. The fair price of Stryker Corp (SYK) is between 384.89 to 433.84 according to relative valuation methord. Compared to the current price of 373.42 USD , Stryker Corp is Undervalued By 2.98%.

Relative Value

Fair Zone

384.89-433.84

Current Price：373.42

2.98%

Undervalued

25.76

Trailing

Forward

20.60

EV/EBITDA

Stryker Corp. (SYK) has a current EV/EBITDA of 20.60. The 5-year average EV/EBITDA is 21.38. The thresholds are as follows: Strongly Undervalued below 18.36, Undervalued between 18.36 and 19.87, Fairly Valued between 22.89 and 19.87, Overvalued between 22.89 and 24.40, and Strongly Overvalued above 24.40. The current Forward EV/EBITDA of 20.60 falls within the Historic Trend Line -Fairly Valued range.

21.93

EV/EBIT

Stryker Corp. (SYK) has a current EV/EBIT of 21.93. The 5-year average EV/EBIT is 23.15. The thresholds are as follows: Strongly Undervalued below 20.06, Undervalued between 20.06 and 21.61, Fairly Valued between 24.69 and 21.61, Overvalued between 24.69 and 26.24, and Strongly Overvalued above 26.24. The current Forward EV/EBIT of 21.93 falls within the Historic Trend Line -Fairly Valued range.

373.44

Stryker Corp. (SYK) has a current PS of 373.44. The 5-year average PS is 9.12. The thresholds are as follows: Strongly Undervalued below -63.92, Undervalued between -63.92 and -27.40, Fairly Valued between 45.64 and -27.40, Overvalued between 45.64 and 82.16, and Strongly Overvalued above 82.16. The current Forward PS of 373.44 falls within the Strongly Overvalued range.

19.75

P/OCF

Stryker Corp. (SYK) has a current P/OCF of 19.75. The 5-year average P/OCF is 26.18. The thresholds are as follows: Strongly Undervalued below 18.05, Undervalued between 18.05 and 22.11, Fairly Valued between 30.25 and 22.11, Overvalued between 30.25 and 34.31, and Strongly Overvalued above 34.31. The current Forward P/OCF of 19.75 falls within the Undervalued range.

25.42

P/FCF

Stryker Corp. (SYK) has a current P/FCF of 25.42. The 5-year average P/FCF is 34.22. The thresholds are as follows: Strongly Undervalued below 25.90, Undervalued between 25.90 and 30.06, Fairly Valued between 38.39 and 30.06, Overvalued between 38.39 and 42.55, and Strongly Overvalued above 42.55. The current Forward P/FCF of 25.42 falls within the Strongly Undervalued range.

Stryker Corp (SYK) has a current Price-to-Book (P/B) ratio of 6.56. Compared to its 3-year average P/B ratio of 6.57 , the current P/B ratio is approximately -0.29% higher. Relative to its 5-year average P/B ratio of 6.53, the current P/B ratio is about 0.38% higher. Stryker Corp (SYK) has a Forward Free Cash Flow (FCF) yield of approximately 0.00%. Compared to its 3-year average FCF yield of 2.22%, the current FCF yield is approximately -100.00% lower. Relative to its 5-year average FCF yield of 2.46% , the current FCF yield is about -100.00% lower.

6.56

P/B

Median3y

6.57

Median5y

6.53

0.00

FCF Yield

Median3y

2.22

Median5y

2.46

Competitors Valuation Multiple

The average P/S ratio for SYK's competitors is 323.60, providing a benchmark for relative valuation. Stryker Corp Corp (SYK) exhibits a P/S ratio of 373.44, which is 15.40% above the industry average. Given its robust revenue growth of 10.25%, this premium appears unsustainable.

P/S

P/E

EV/EBITDA

EV/EBIT

P/S

Revenue Growth

Market Cap

Boston Scientific Corp

Intuitive Surgical Inc

Thermo Fisher Scientific Inc

580.32

4.94%

217.96B

Performance Decomposition

Market capitalization of SYK decreased by 4.55% over the past 1 year. The primary factor behind the change was an increase in Revenue Growth from 5.49B to 6.06B.

The secondary factor is the Margin Expansion, contributed -6.59%to the performance.

Overall, the performance of SYK in the past 1 year is driven by Revenue Growth. Which is more sustainable.

10.25%

5.49B → 6.06B

Revenue Growth

-6.59%

15.18 → 14.18

Margin Expansion

-8.21%

53.45 → 49.06

P/E Change

-4.55%